Impairment and Other Accounting Estimates Reflecting the Impact of COVID-19
First written in FY2021-Q1. 7 of 11 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2026: 4 of 8 companies on the "Worse" side.
40 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「Estimates of future cash flows used to determine whether impairment losses should be recognized are based on a business plan approved by the Board of Directors. However, because the plan incorporates, as key assumptions, the effects of performance improvement measures such as increased net sales from sales initiatives and cost reductions from expense-reduction initiatives, certain adjustments have been made.」
The Group continued to explain that the business plan incorporating the effects of sales initiatives and expense-reduction measures and real estate valuations, rather than the duration of the impact of COVID-19, were key assumptions in estimating impairment. - FY2024RestatedAnnual report
「Estimates of future cash flows used to determine whether impairment losses should be recognized are based on a business plan approved by the Board of Directors. However, because the plan incorporates, as key assumptions, the effects of performance improvement measures such as increased net sales from sales initiatives and cost reductions from expense-reduction initiatives, certain adjustments have been made.」
The Group continued to state that the business plan incorporating the effects of sales initiatives and expense-reduction measures, rather than the duration of the impact of COVID-19, was a key assumption in estimating impairment. - FY2023ReframedAnnual report
「Estimates of future cash flows used to determine whether impairment losses should be recognized are based on a business plan approved by the Board of Directors. However, because the plan incorporates, as key assumptions, the effects of performance improvement measures such as increased net sales from sales initiatives and cost reductions from expense-reduction initiatives, certain adjustments have been made.」
The explanation shifted from estimates centered on the duration of the impact of COVID-19 to one centered on the effects of sales initiatives and expense-reduction measures and the uncertainty of real estate valuations. - FY2023-Q3RestatedAnnual report
「For impairment accounting for fixed assets and other matters, the Group prepares accounting estimates based on the assumption that the impact of the decline in net sales and other effects resulting from the spread of COVID-19 would continue through the fiscal year ending March 2023, taking into account factors such as the locations of its stores. There have been no material changes to the assumptions described in the Additional Information section of the annual securities report for the previous consolidated fiscal year, including assumptions regarding the future spread of COVID-19 and the timing of its containment.」
The Group continued to use the accounting assumption that the impact of COVID-19 would continue through the fiscal year ending March 2023, with no material changes from the previous consolidated fiscal year. - FY2023-Q1RestatedAnnual report
「For impairment accounting for fixed assets and other matters, the Group prepares accounting estimates based on the assumption that the impact of the decline in net sales and other effects resulting from the spread of COVID-19 would continue through the fiscal year ending March 2023, taking into account factors such as the locations of its stores.」
The Group continued to use the accounting assumption that the impact of the decline in net sales and other effects caused by COVID-19 would continue through the fiscal year ending March 2023, with no material changes from the previous consolidated fiscal year. - FY2022Assumed period of the impact of COVID-19 extended through the fiscal year ending March 2023Annual report
「For impairment accounting for fixed assets and other matters, the Group prepares accounting estimates based on the assumption that the impact of the decline in net sales and other effects resulting from the spread of COVID-19 would continue through the fiscal year ending March 2023, taking into account factors such as the locations of its stores.」
The assumed accounting period for the impact of COVID-19 was extended from the fiscal year ending March 2022 to the fiscal year ending March 2023. - FY2022-Q3RestatedAnnual report
「For impairment accounting for fixed assets and other matters, the Group prepares accounting estimates based on the assumption that the impact of the decline in net sales and other effects resulting from the spread of COVID-19 would continue through the fiscal year ending March 2022, taking into account factors such as the locations of its stores. There have been no material changes to the assumptions described in the Additional Information section of the annual securities report for the previous consolidated fiscal year, including assumptions regarding the future spread of COVID-19 and the timing of its containment.」
The Group continued to state its accounting estimate that the decline in net sales and other effects caused by COVID-19 would continue through the fiscal year ending March 2022, and that there had been no material changes to the assumptions. - FY2022-Q2RestatedAnnual report
「For impairment accounting for fixed assets and other matters, the Group prepares accounting estimates based on the assumption that the impact of the decline in net sales and other effects resulting from the spread of COVID-19 would continue through the fiscal year ending March 2022, taking into account factors such as the locations of its stores.」
The Group continued to state its accounting assumption that the impact of the decline in net sales and other effects caused by COVID-19 would continue through the fiscal year ending March 2022, with no material changes from the previous fiscal year. - FY2022-Q1Assumed period of the impact of COVID-19 extended through the fiscal year ending March 2022Annual report
「For impairment accounting for fixed assets and other matters, the Group prepares accounting estimates based on the assumption that the impact of the decline in net sales and other effects resulting from the spread of COVID-19 would continue through the fiscal year ending March 2022, taking into account factors such as the locations of its stores.」
The assumption was changed from the previous assumption of a gradual recovery from July 2020 onward to an assumption that the impact of the decline in net sales and other factors would continue through the fiscal year ending March 2022. - FY2021-Q3RestatedAnnual report
「For impairment accounting for fixed assets and other matters, the Group prepares accounting estimates based on the assumption that the substantial decline in net sales and negative operating cash flow resulting from the spread of COVID-19 would continue through June 2020 and that a gradual recovery would begin from July 2020 onward, taking into account factors such as the locations of its stores. There have been no material changes to the assumptions described in the Additional Information section of the annual securities report for the previous consolidated fiscal year, including assumptions regarding the future spread of COVID-19 and the timing of its containment.」
The Group continued to use its assumptions regarding the impact of COVID-19 in estimating impairment of fixed assets and other items, and stated that there had been no material changes from the previous consolidated fiscal year. - FY2021-Q1First statedAnnual report
「For impairment accounting for fixed assets and other matters, the Group prepares accounting estimates based on the assumption that the substantial decline in net sales and negative operating cash flow resulting from the spread of COVID-19 would continue through June 2020 and that a gradual recovery would begin from July 2020 onward, taking into account factors such as the locations of its stores.」
The Group used, in estimating impairment of fixed assets and other items, the assumption that the decline in net sales and negative operating cash flow caused by COVID-19 would continue through June 2020 and gradually recover from July 2020 onward.